MEDTRONIC PLC

20 November, 2024

Medtronic Showcases Innovations at CIIE, Faces Competition in Atrial Fibrillation Treatment Market and Prepares for Q2 Earnings Report

Medtronic recently showcased its innovations in medical technology at the 7th China International Import Expo, marking its seventh consecutive participation in the event. Among the seven new products ...
Read More

19 November, 2024

Medtronic Secures FDA Approval for Groundbreaking PulseSelect PFA System and Affera Mapping Technology, Enhancing AFib Treatment Options Amidst Intensifying Competition

Medtronic plc (MDT) has recently achieved a significant milestone by receiving FDA approval for its PulseSelect pulsed field ablation (PFA) system, making it the first PFA technology authorized for th...
Read More

18 November, 2024

Medtronic Addresses Pulse Oximeter Lawsuit and Expands Market Presence Amid Legal Challenges and Regulatory Developments

Medtronic has been in the news for both legal challenges and significant advancements in its product offerings. Recently, the company settled a lawsuit concerning the accuracy of its pulse oximeters f...
Read More

17 November, 2024

Medtronic Navigates Competitive Landscape in Medical Devices Amid Patent Lawsuits and Product Innovation

Medtronic plc (MDT) continues to be a prominent player in the medical technology sphere, particularly in the cardiac device sector. Recently, Medtronic actively engaged in the U.S. atrial fibrillation...
Read More